Healthcare entity
Every one of those 1 sits in a single category, regulation. Of the tracked stories, 1 of 1 also mention Drugs for Neglected Diseases initiative (DNDi), the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 4.3 for the same window.
Last mentioned: Mar 16, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, regulation. Of the tracked stories, 1 of 1 also mention Drugs for Neglected Diseases initiative (DNDi), the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 4.3 for the same window. At 8, the average consequence score sits above the same-window beat average of 5.9. We currently track 1 Healthcare story that mention Acoziborole, all published on March 16, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Acoziborole. Shared-story counts are live from our verified record — not editorial picks.
Rollout Milestone
Acoziborole enters the final stages of regulatory rollout for endemic regions.
Trial Results
Phase 2/3 clinical trial results for Acoziborole show high efficacy.
Fexinidazole Approval
First all-oral 10-day treatment for sleeping sickness is approved.
Research Begins
DNDi starts screening compounds for a single-dose HAT treatment.
The introduction of Acoziborole, a single-dose oral medication, marks a pivotal shift in the global fight against Human African Trypanosomiasis. This breakthrough treatment simplifies complex therapeutic regimens, potentially enabling the total elimination of the disease by 2030.
Acoziborole is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
